Albany, New York, March 29, 2017: MarketResearchReports.biz has recently announced the addition of a detailed market research report on the global market for blood stream infection to its vast market research report portfolio. The report, titled “Global Blood Stream Infection Testing Market 2016-2020,” analyzes the overall growth prospects of the market over the period between 2016 and 2020.
The report states that the market will be driven due to the rising adoption of digital technologies across the healthcare industry, a trend driven by the need to deliver patient-centric healthcare services for companies to survive the intense competition in the global market. The market is expected to exhibit a promising 8% CAGR over the said period.
On the basis of product type, the global blood stream infection testing market has been segmented in the report into instruments and consumables. Of these, the segment of consumables accounted for the leading share in the valuation of the global market and is expected to retain dominance over the report’s forecast period as well. Consumables are used in bulk for analysis of blood samples during any test concerning the infection of blood stream. The segment of consumables is thus one that is capable of generating more returns on investment than the segment of instruments.
On the basis of end-use sectors, the global market for blood stream infection testing has been segmented in the report into diagnostics clinical laboratories and hospitals. Of these, the segment of hospitals accounted for the leading share in the global market in 2015 and is expected to retain the dominant position over the report’s forecast period as well. As most blood infections develop in hospitals, especially in intensive care departments, blood stream infection tests are mostly carried out in hospital-based laboratories. Moreover, an increased number of hospitals are providing technologically advanced testing services, expected to bring a rise in consumers opting to undertake tests in hospitals.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/877641
From a geographical perspective, the global market for blood stream infection testing market is dominated by the Americas market, which contributed the largest share in revenue to the global market in 2015. The region is expected to retain dominance over the forecast period as well, riding on the back of the rising awareness regarding blood transfusion-transmitted infections and the importance of blood safety in countries such as Canada and the U.S. The high need of blood transfusions in these countries owing to the high prevalence of blood-related disorders has led to the increased demand for blood donations and the subsequent rise in need for effective blood stream infection tests.
The global market for blood stream infection testing features the presence of several well-established regional as well as global companies. Some of the leading vendors in the market are Roche Diagnostics, Thermo Fisher Scientific, Cepheid, bioMérieux, Eurogentec, AdvanDX, Alere, IRIDICA, Nanosphere, Beckman Coulter, Dade Behring, Bruker, AB Sciex, and Siemens.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com